loading
前日終値:
$8.43
開ける:
$8.44
24時間の取引高:
70,953
Relative Volume:
0.46
時価総額:
$321.84M
収益:
$128.45M
当期純損益:
$6.54M
株価収益率:
171.60
EPS:
0.05
ネットキャッシュフロー:
$-8.79M
1週間 パフォーマンス:
+5.99%
1か月 パフォーマンス:
+5.08%
6か月 パフォーマンス:
+15.39%
1年 パフォーマンス:
+33.52%
1日の値動き範囲:
Value
$8.40
$8.75
1週間の範囲:
Value
$7.95
$8.75
52週間の値動き範囲:
Value
$4.76
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
名前
Lifecore Biomedical Inc
Name
セクター
Healthcare (1120)
Name
電話
(952) 368-4300
Name
住所
3515 LYMAN BOULEVARD, CHASKA
Name
職員
406
Name
Twitter
Name
次回の収益日
2026-01-22
Name
最新のSEC提出書
Name
LFCR's Discussions on Twitter

LFCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
8.59 315.84M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
124.03 55.12B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.97 50.80B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.27 45.60B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.64 36.04B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
470.62 20.23B 3.08B 1.24B 1.07B 25.61

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-04 開始されました KeyBanc Capital Markets Sector Weight
2025-05-21 開始されました William Blair Outperform
2024-09-05 開始されました Craig Hallum Buy
2024-08-28 ダウングレード Barrington Research Outperform → Mkt Perform
2023-03-20 ダウングレード Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc (LFCR) 最新ニュース

pulisher
11:08 AM

Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire

11:08 AM
pulisher
Jan 20, 2026

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity - simplywall.st

Jan 20, 2026
pulisher
Jan 19, 2026

Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire

Jan 19, 2026
pulisher
Jan 18, 2026

2026-01-18 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse

Jan 18, 2026
pulisher
Jan 17, 2026

(LFCR) Risk Channels and Responsive Allocation - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 16, 2026

Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit - Law360

Jan 16, 2026
pulisher
Jan 16, 2026

Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan - TipRanks

Jan 16, 2026
pulisher
Jan 16, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jan 16, 2026
pulisher
Jan 16, 2026

What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage? - Insider Monkey

Jan 16, 2026
pulisher
Jan 16, 2026

Townhall - FinancialContent

Jan 16, 2026
pulisher
Jan 15, 2026

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Jan 15, 2026
pulisher
Jan 14, 2026

Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire

Jan 14, 2026
pulisher
Jan 14, 2026

Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha

Jan 14, 2026
pulisher
Jan 13, 2026

Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile

Jan 13, 2026
pulisher
Jan 13, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jan 13, 2026
pulisher
Jan 12, 2026

Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Clai - GlobeNewswire

Jan 12, 2026
pulisher
Jan 12, 2026

Whittier Daily News - FinancialContent

Jan 12, 2026
pulisher
Jan 11, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jan 11, 2026
pulisher
Jan 10, 2026

Insider Trends: Why Lifecore Biomedical Inc stock could rally in 20252025 Risk Factors & Stepwise Trade Signal Guides - Bộ Nội Vụ

Jan 10, 2026
pulisher
Jan 10, 2026

Aug Selloffs: Why Lifecore Biomedical Inc. stock attracts high net worth investors2025 Market Sentiment & Stock Market Timing Techniques - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Pullback Watch: Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Beh - GlobeNewswire

Jan 09, 2026
pulisher
Jan 09, 2026

About Us - FinancialContent

Jan 09, 2026
pulisher
Jan 08, 2026

Why Lifecore Biomedical Inc. stock attracts high net worth investorsDividend Hike & Low Volatility Stock Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Lifecore Biomedical Inc. stock dividend yield sustainableWeekly Market Report & Daily Stock Trend Watchlist - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Why Lifecore Biomedical Inc. stock could rally in 2025July 2025 Volume & Risk Adjusted Buy and Sell Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How institutional buying supports Lifecore Biomedical Inc. stock2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile

Jan 08, 2026
pulisher
Jan 08, 2026

Why Lifecore Biomedical Inc. stock is a must watch in 2025Market Activity Recap & Weekly Setup with ROI Potential - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Activity Recap: Why Lifecore Biomedical Inc. stock is a must watch in 2025Trade Exit Report & Reliable Breakout Forecasts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Lifecore Biomedical Inc. stock gain from lower inflationJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire

Jan 08, 2026
pulisher
Jan 07, 2026

Published on: 2026-01-07 20:37:50 - Улправда

Jan 07, 2026
pulisher
Jan 07, 2026

MSN Money - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, ... - Bluefield Daily Telegraph

Jan 07, 2026
pulisher
Jan 07, 2026

Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Jan 07, 2026
pulisher
Jan 07, 2026

KeyBanc says momentum, strategic value building at Lifecore - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Operating cash flow per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 06, 2026

How sustainable is Lifecore Biomedical Inc. stock dividend payout2026 world cup usa national team semifinals defensive leaders set piece tactics knockout prediction expert opinion - Улправда

Jan 06, 2026
pulisher
Jan 06, 2026

2026-01-06 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse

Jan 06, 2026
pulisher
Jan 06, 2026

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

(LFCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jan 06, 2026
pulisher
Jan 05, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jan 05, 2026
pulisher
Jan 05, 2026

Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire

Jan 05, 2026
pulisher
Jan 05, 2026

Press Telegram - FinancialContent

Jan 05, 2026
pulisher
Jan 04, 2026

2026-01-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse

Jan 04, 2026
pulisher
Jan 04, 2026

Lifecore Biomedical (NASDAQ:LFCR) Upgraded at Zacks Research - Defense World

Jan 04, 2026
pulisher
Jan 03, 2026

Can IDBI Bank Limited Rally Enough to Break EvenRelative Strength Index (RSI) & Big Gains Small Budget - earlytimes.in

Jan 03, 2026
pulisher
Jan 03, 2026

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR) - The Globe and Mail

Jan 03, 2026
pulisher
Jan 01, 2026

Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha

Jan 01, 2026
pulisher
Dec 31, 2025

Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire

Dec 31, 2025

Lifecore Biomedical Inc (LFCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Lifecore Biomedical Inc (LFCR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
English Aron R.
10% Owner
May 28 '25
Sale
7.12
150,419
1,071,555
264,180
English Aron R.
10% Owner
May 23 '25
Sale
6.75
96,137
649,386
1,554,103
English Aron R.
10% Owner
May 13 '25
Sale
7.00
12,334
86,353
1,650,240
English Aron R.
10% Owner
May 12 '25
Sale
7.03
45,698
321,426
1,662,574
English Aron R.
10% Owner
May 08 '25
Sale
7.00
5,098
35,693
1,708,972
English Aron R.
10% Owner
May 09 '25
Sale
7.00
700
4,900
1,708,272
English Aron R.
10% Owner
May 05 '25
Sale
7.08
24,543
173,831
1,730,618
English Aron R.
10% Owner
May 07 '25
Sale
7.01
15,847
111,099
1,714,070
English Aron R.
10% Owner
May 06 '25
Sale
7.05
701
4,940
1,729,917
drug_manufacturers_specialty_generic RDY
$13.72
price up icon 3.40%
$24.87
price up icon 2.41%
$137.46
price up icon 1.52%
drug_manufacturers_specialty_generic RGC
$30.31
price up icon 39.11%
$13.25
price up icon 1.40%
$470.62
price up icon 0.15%
大文字化:     |  ボリューム (24 時間):